Drawing for SWEET SLEEP

USPTO serial 99310621

SWEET SLEEP

Reviewed by CopyMark Law Group

Status 681
Filing date
Status date
Registration date
—
Examiner
CLONCH, ABIGAIL
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with SWEET SLEEP?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Kristen S Ruisi

Kristen S Ruisi Venable LLP151 W. 42nd Street, 49th FloorNew York, NY 10036United States

Goods and services

ClassDescriptionStatusFirst use
005Dietary and nutritional supplements; Vitamin supplements; Dietary and nutritional supplements in the form of powdered sticks, powders, liquids, gummies, capsules, chews, gels, tablets, shots and barsACTIVE—
035Online retail store services featuring a wide variety of consumer goodsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 4, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 8, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 21, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 8, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 8, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 8, 2026NREVNOTICE OF REVIVAL - E-MAILED—
Sep 8, 2026PETGPETITION TO REVIVE-GRANTED—
Sep 8, 2026PROATEAS PETITION TO REVIVE RECEIVED—
Jul 7, 2026MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jul 7, 2026ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Feb 5, 2026XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Feb 5, 2026XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Dec 23, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 23, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 23, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 15, 2025DOCKASSIGNED TO EXAMINER—
Jul 30, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 30, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 30, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance